Results 61 to 70 of about 219,023 (115)

Camelid VHHs as a Versatile Platform for Combating Viral Infections. [PDF]

Pharmaceuticals (Basel)
Mufrrih M, Alandijany TA.
europepmc   +1 more source

Protocol for model-guided alternating high-temperature thermotherapy to eliminate major viruses from diverse sugarcane cultivars. [PDF]

STAR Protoc
Huang GQ, Guo JL, Li F, Dong Q, Hsieh TY.   +4 more
europepmc   +1 more source

Next-generation oncolytic virotherapy for lung cancer: bridging innovative vector engineering with clinical immunotherapy. [PDF]

Transl Lung Cancer Res
Liu J, Zeng R, Li G, Wang J, Xiong A, He X.   +5 more
europepmc   +1 more source

Peptide Aptamers: Innovative Design and Applications in Pathogen Detection. [PDF]

Chembiochem
Wu S, Wu X, Wen J, Chen J, Liu T, Gu D.
europepmc   +1 more source

Engineering strategies to address immune and delivery barriers in pancreatic ductal adenocarcinoma: a barrier-matched translational framework. [PDF]

Front Immunol
Li Y, Li Y, Fan J, San ZQ, Ye JF.
europepmc   +1 more source

AI-guided epitope engineering of a SARS-CoV-2 spike antigen for broad sarbecovirus neutralization. [PDF]

Front Immunol
Odainic A, Vardaxis I, Ferraz M, Wiese KE, Cornelissen LAHM, Sharma A, Stratford R, Clancy T, Bendjama K.   +8 more
europepmc   +1 more source

Delivery Strategies for Oncolytic Viruses in Gastrointestinal Cancers: Progress, Mechanisms and Clinical Translations. [PDF]

Rev Med Virol
Xue C, Liu Y, Yin C, Guo R, Ju M, Zhang Y, Xiao F, Wang X, Iko H, Guo ZS, Zhu Z.   +10 more
europepmc   +1 more source

Emerging Oncolytic Viruses: Beyond Adenoviruses and Herpes Simplex Virus. [PDF]

J Cancer
Chokkakula S, Yin C, Yang B, Chong S, Pathakumari B, Zhang YQ, Nirmala PV, Lai KW, Naveen B, Tang Q.   +9 more
europepmc   +1 more source

Corrigendum to "Avian herpesvirus-specific LORF5 is a late gene,interacts with 19 viral and 111 host proteins, critical for virulence of Duck plague virus" [Poultry Science, Volume 105, Issue 7, July 2026, 106924]. [PDF]

Poult Sci
Li H, Cheng A, Wang M, Zhang W, Yang Q, Ou X, Sun D, He Y, Tian B, Wu Z, Zhang S, Huang J, Wu Y, Yu Y, Zhang L, Zhao X, Zhu D, Chen S, Jia R, Liu M.   +19 more
europepmc   +1 more source

Systemic removal of host restriction factors enables rapid, scalable virus production for cell culture-based vaccine development. [PDF]

Front Bioeng Biotechnol
Xu Z, Jeon J, Oh J, Shin Y, Park SH.
europepmc   +1 more source